ClinVar Miner

Submissions for variant NM_000261.2(MYOC):c.144G>T (p.Gln48His)

gnomAD frequency: 0.00001  dbSNP: rs74315339
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Glaucoma Variant Curation Expert Panel RCV001843352 SCV002102554 likely benign Glaucoma of childhood 2022-03-05 reviewed by expert panel curation The c.144G>T variant in MYOC is a missense variant predicted to cause substitution of Glutamine by Histidine at amino acid 48 (p.Gln48His). The highest minor allele frequency of this variant was in the South Asian population of gnomAD (v2.1.1) = 0.007937, which met the >= 0.001 threshold set for BS1 (243 alleles out of 30,616, meeting the threshold of >= 5 of at least 2,000 observed alleles). The REVEL score = 0.257, which was neither above nor below the thresholds for PP3 (>= 0.7) or BP4 (<= 0.15), predicting a damaging or benign impact on MYOC function. Previous studies (PMIDs: 16466712 and 35196929) demonstrated that the Gln48His protein had similar solubility and secretion levels to wild type myocilin protein and met the OddsPath threshold for BS3_Moderate (< 0.23), indicating that this variant did not impact protein function. As BS1 was met, PP1 did not apply and segregations were not counted. Although probands with juvenile or primary open angle glaucoma have been reported carrying this variant, PM2_Supporting was not met, therefore PS4 did not apply. In summary, this variant met the criteria to receive a score of - 6 and to be classified as likely benign (likely benign classification range - 2 to - 6) for juvenile open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v1, 12 Oct 2021): BS1, BS3_Moderate.
Illumina Laboratory Services, Illumina RCV000296614 SCV000351312 pathogenic MYOC-related disorder 2017-08-30 criteria provided, single submitter clinical testing Across a selection of the available literature, the MYOC c.144G>T (p.Gln48His) missense variant has been identified in a homozygous state in one individual with primary congenital glaucoma (PCG), and in a heterozygous state in 13 individuals with primary open angle glaucoma, eight with PCG, four with juvenile open angle glaucoma and five with microcoria and glaucoma (Mukhopadhyay et al. 2002; Sripriya et al. 2004; Chakrabarti et al. 2005; Kaur et al. 2005; Ramprasad et al. 2005; Kumar et al. 2007; Rose et al. 2011; Banerjee et al. 2012). The variant was absent from 1110 ethnically matched controls but is reported with a frequency of 0.02451 in the Sri Lankan Tamil in the UK population of the 1000 Genomes Project. This allele frequency is high but is consistent with the variant being one of the most commonly reported and well-described variants associated with glaucoma in the South Asian population (Sripriya et al. 2004; Ramprasad et al. 2005). The Gln48 residue is conserved. Based on the collective evidence, the p.Gln48His variant is classified as pathogenic for MYOC-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.
Invitae RCV001520657 SCV001729816 benign not provided 2023-02-02 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV000008421 SCV002798955 likely benign Glaucoma 1, open angle, A 2022-05-17 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV000296614 SCV004772210 likely benign MYOC-related disorder 2022-08-24 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
OMIM RCV000008421 SCV000028629 pathogenic Glaucoma 1, open angle, A 2005-04-01 no assertion criteria provided literature only
OMIM RCV000008422 SCV000028630 pathogenic Glaucoma 3, primary congenital, a, digenic 2005-04-01 no assertion criteria provided literature only
Reproductive Health Research and Development, BGI Genomics RCV000008421 SCV001142312 pathogenic Glaucoma 1, open angle, A 2020-01-06 no assertion criteria provided curation NM_000261.1:c.144G>T in the MYOC gene has an allele frequency of 0.008 in South Asian subpopulation in the gnomAD database.The MYOC c.144G>T (p.Gln48His) missense variant was identified in 4 of the 450 POAG patients (PMID: 22736945) and in two POAG patients from Chennai (PMID: 22194650). It was also observed in five of the eight glaucoma patients (PMID: 16288197). Chakrabarti S et al reported that the Gln48His mutation was detected in 9 different glaucoma patients (four POAG and five PCG) and all four POAG cases were heterozygous, among PCG cases, four were heterozygous and one exhibited homozygous genotype for the mutation(PMID: 15723004). Taken together, we interprete this variant as Pathogenic/Likely pathogenic. ACMG/AMP Criteria applied: PS3, PS4, PP4

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.